Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 24, 2008 to Discuss First Quarter 20...( WALTHAM Mass. April 17 /- Inverne...),Health
Navigation Links
Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 24, 2008 to Discuss First Quarter 2008 Results
Date:4/17/2008
WALTHAM, Mass., April 17 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a global leader in rapid point-of-care diagnostic products, today announced that it will release its first quarter 2008 earnings on Thursday, April 24, 2008. The Company will also host a conference call beginning at 10:00 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call the Company may discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.
The conference call may be accessed by dialing 973-582-2700 (domestic and international), an access code is not required, or via a link on the Inverness website at http://www.invernessmedical.com. It is also available via link at http://audioevent.mshow.com/343993/ using Real Player or Windows Media. An on-demand webcast of the call will be available at the Inverness website (http://www.invernessmedical.com/News.cfm) two hours after the end of the call and will be accessible for 30 days.
By developing new capabilities in near-patient diagnosis, monitoring
and health management, Inverness Medical Innovations enables individuals to
take charge of improving their health and quality of life. A global leader
in rapid point-of-care diagnostics, Inverness' products, as well as its new
product development efforts, focus on infectious disea
'/>"/>
| SOURCE Inverness Medical Innovations, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Inverness Completes Acquisition of Cholestech
2. Inverness Medical Innovations Acquires Bio-Stat Healthcare Group
3. Inverness Medical Innovations Acquires Alere Medical
4. Inverness Medical Innovations Announces Closing of Public Offering
5. Inverness Medical Innovations to Participate at 2007 RBC Healthcare Conference on December 12, 2007
6. Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory
7. Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
8. Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008
9. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 20, 2008 to Discuss Fourth Quarter 2007 Results
10. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of Inverness Medical Innovations, Inc. Who Invested in the Inverness Medical Innovations, Inc. Employee Savings Plan
11. Correction: Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Inverness Medical Innovations, Inc.
Post Your Comments:
(Date:11/8/2009)...wire/ -- Jon O,Brien, president of Catholics for C...ssage of HR 3962: ,, "Behavior in recent weeks... values. We in the prochoice community stayed true...gles ordinary Americans have making ends meet. The...althcare or have to choose between maintaining the...
(Date:11/8/2009)...self-assurance, research finds , , SUNDA... been right when she told you to sit up straight: ... you feel more confident about your thoughts. ,... gives a good impression to other people," Richard...ofessor at Ohio State University, said in a univer...
(Date:11/8/2009)...wire/ -- Speaker Nancy Pelosi and Democratic leade...sage of H.R. 3962, the Affordable Health Care for ...215. Below are the Speaker,s opening remarks: ,...all from the President of the United States, Barac...the American people. I thank the President for his...
(Date:11/8/2009)...biopharmaceuticals to be available at the Company&... Toronto, ON (PRWEB) November 8, 2...ure Biopharma Inc. today announced that the Compan...eutical grade freeze dryer and expects to make com...able for contract manufacturing of biopharmaceutic...
(Date:11/8/2009)...e is won," said Dr. Charmaine Yoest. ,, WASHIN...of 240-194, the Stupak-Ellsworth-Pitts-Kaptur-Dahl...on mandates and funding in HR 3962 passed on the H... President and CEO Dr. Charmaine Yoest said, "The ...-life Americans across this country who have flood...
Breaking Medicine News(10 mins):Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:Good Posture May Inspire Confidence 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2[1] Catholics for Choice Statement on Healthcare Reform Bill[1] Good Posture May Inspire Confidence[0] Pelosi Remarks at Press Conference Following Passage of the Affordable Health Care for America Act[0] Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer [1] Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People
...ces may be causing the surface of the earth to sli...erican scientists, which has been published by the...Carlo Doglioni of Rome's La Sapienza University an... into vast plates that slowly shift, producing ear...
...tion from Singapore in search of 'Bigfoot', an ape...een postponed until 21 January 2006. //This has be...aysia. This has been revealed by the Singapore Par...of 20 members to solve it. Three of the creatures,...
...sian market vendor who came into close contact wit... H5N1 strain of the bird flu virus.// Health autho...onfirmed that the 22-year-old man carried the viru... toll in the country will rise to 15.
The WHO ...
...released by China's Ministry of Health, the World ...V/AIDS cases prevailing in the country, //is raisi...y quoted, the New York Times reports.
A repor...e number of full-blown cases at 75,000. The report...
...h Secretary of Britain is planning to introduce a ...s aimed at reducing long hours of waiting to avail...The new facility will allow the patients to see th... their appointment in big hospitals which does not...
...ficials in India have revealed that the country is...ountry has set itself a target of less than one le...ing the early 1980s, when the Multi Drug Therapy (...er 2005. //
At least 11.27 million leprosy c...
Other Medicine News:(Date:11/6/2009)...., Nov. 6 Philips Respironics appl...l and Prevention (CDC) to raise awareness about an...sufficiency. The CDC,s release of the first-ever g...ces in sleeplessness is a milestone in quantifying...ng-time educator, industry leader and sleep therap...
(Date:11/6/2009)... 6 Ardea Biosciences, In...ed on the development of small-molecule therapeuti...unodeficiency virus (HIV), today reported recent a... quarter and nine months ended September 30, 2009....nh/20091104/ARDEALOGO ) ,, "Since our last quar...
(Date:11/6/2009)...LE PARK, N.C., Nov. 6 Chimerix, In...vailable antiviral therapeutics to address life-th...opment of the company,s lead antiviral compound, C...the Global Health Security Initiative (GHSI). CMX...loped for the treatment of smallpox, as well as ot...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Research Finds New Crop of Breast Cancer Genes 47543 1Research Finds New Crop of Breast Cancer Genes 47543 2New Study Documents High Prevalence of Serious Mental Illnesses Among Nations Jail Populations 47540 1New Study Documents High Prevalence of Serious Mental Illnesses Among Nations Jail Populations 47540 2Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 1Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 2Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 3Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 4Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 5[0] Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation[0] Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results[0] Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
... Cadence Pharmaceuticals,Inc. (Nasdaq: CADX ), a ...developing and commercializing proprietary product...tting, today announced that it will release its,se...pens on Thursday,August 7, 2008., Cadence managem...o,discuss the financial results and provide a clin...
...nalyses Have Conflicting Results -, CHICAGO, July...nking processes among placebo groups in Alzheimer,... to show the effectiveness,of new Alzheimer therap...he,2008 Alzheimer,s Association International Conf...go., Alzheimer clinical trials seek to show that ...
Other Medicine Technology:Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008 2Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 2Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 3Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 4Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 5| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |